Aprepitant/Fosaprepitant Dimeglumine and Cisatracurium Besylate Injection
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Cisatracurium Besylate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: cisatracurium
Brand name: Nimbex
Synonyms: Cisatracurium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Cisatracurium besylate Intravenous
- Aprepitant/Fosaprepitant Dimeglumine-Cisplatin
- Aprepitant/Fosaprepitant Dimeglumine-Cisplatin Intravenous
- Aprepitant/Fosaprepitant Dimeglumine-Citalopram
- Aprepitant/Fosaprepitant Dimeglumine-Citalopram Capsules
- Aprepitant/Fosaprepitant Dimeglumine-Citalopram Hydrobromide
- Cisatracurium Besylate Injection-Apresazide
- Cisatracurium Besylate Injection-Apresoline
- Cisatracurium Besylate Injection-Apresoline Injection
- Cisatracurium Besylate Injection-Apri
- Cisatracurium Besylate Injection-Apriso
- Cisatracurium Besylate Injection-Aprizio Pak